Evion Group NL Lists 570,000 Shares After Exercising Options at $0.03 Strike Price on ASX

Details on EVG’s Option Exercise and Share Quotation Process

Evion Group NL has submitted an ASX quotation application after converting 570,000 EVGAT options into ordinary shares. These options, expiring on 27 September 2026 with a strike price of AUD $0.03, were exercised during a defined period from 7 to 10 July 2026. The resulting shares were issued on 21 July 2026 and rank equally with existing ordinary shares in all respects from that date.

Option exercises serve as a common method for listed companies like EVG to increase their shareholder base and capital without conducting a separate capital raise. Typically, option holders convert when the underlying share price exceeds the strike price or when options near expiry. In this case, the $0.03 strike price set the threshold for conversion into ordinary shares.

Impact on Capital Structure Following Option Conversion

With the addition of these 570,000 shares, Evion Group NL’s quoted share capital expands to 734,727,496 ordinary fully paid shares on the ASX. This significant increase enhances the liquidity and market availability of EVG shares for investors.

EVG continues to hold a large portfolio of unquoted convertible securities, including 60,231,722 EVGAT options expiring 27 September 2026 at the same $0.03 strike price. Additionally, the company holds 19,750,000 options expiring 22 November 2027 at $0.05 per share, 8,000,000 options expiring 22 November 2027 at $0.04 per share, and 4,392,186 partly paid ordinary shares. The company also maintains 45,400,000 performance rights across multiple series, including 13,400,000 expiring 22 November 2027, 2,000,000 expiring 30 June 2027, and 6,000,000 from the 2023 series.

ASX Compliance and Equal Ranking of Newly Issued Shares

The quotation confirms that the 570,000 shares issued on 21 July 2026 rank equally with existing ordinary shares, ensuring identical voting rights, dividend entitlements, and capital distribution rights. This equality complies with ASX listing rules and protects all shareholders from preferential treatment or dilution.

Evion Group clarified that these securities are not part of an employee incentive scheme, indicating the option exercises were open to the broader shareholder base rather than restricted to staff or executives. The quotation process follows ASX Listing Rules Appendix 2A, ensuring transparency and proper market disclosure.

Timing and Market Context of Option Exercises

The option exercise window spanned four days, from 7 to 10 July 2026. While the company did not disclose specific reasons for this timing, it likely reflects market conditions or strategic decisions by option holders. The shares were issued 11 days later on 21 July 2026, consistent with standard ASX settlement timelines.

Remaining Unquoted Convertible Securities and Potential Future Dilution

Evion Group NL retains a substantial volume of unquoted options and performance rights that may convert into ordinary shares in the future. The largest remaining unquoted option series includes 60,231,722 EVGAT options expiring 27 September 2026 at $0.03 strike price, approaching expiry within three months.

Other convertible securities include 27,750,000 options expiring in November 2027 at $0.04 and $0.05 strike prices, 45,400,000 performance rights with expiry dates between June and November 2027, and 4,392,186 partly paid shares. These instruments represent potential dilution risks to existing shareholders as they convert or are exercised.

Implications of Share Capital Expansion for Current Shareholders

The recent exercise and quotation of 570,000 shares modestly increase EVG’s quoted capital. However, the company’s total unquoted convertible securities of approximately 96.6 million represent about 13% of the current quoted share register, indicating significant potential dilution depending on future conversion activity.

Shareholders should be aware that if EVG’s share price rises above the exercise prices of outstanding options ($0.03, $0.04, and $0.05), option holders are economically incentivized to convert, which could dilute existing ownership. Conversely, if share prices remain below these strike levels, many options may expire unexercised.

Currency and Pricing Details for Option Exercises

All option exercises were conducted at an exercise price of AUD $0.03 per share, consistent with EVG’s Australian domicile and ASX listing. This fixed strike price provided option holders with a clear economic benchmark for conversion decisions during the 7-10 July 2026 exercise window.

Regulatory Adherence and ASX Quotation Procedures

Evion Group NL’s quotation application, submitted via ASX Appendix 2A, confirms compliance with ASX Listing Rules regarding securities issuance and conversion. The application details the exercise mechanics and resulting capital structure, ensuring market transparency and proper shareholder dilution disclosure.

The 570,000 shares issued are classified within an existing ordinary share class, simplifying regulatory approval and ensuring identical treatment with the 734+ million ordinary shares already trading on the ASX.

Investor Guidance and Future Outlook for EVG Shareholders

Upon ASX approval, the 570,000 newly issued shares will be tradable on the exchange. Investors should monitor EVG’s capital structure updates and announcements related to the exercise or conversion of remaining unquoted options and performance rights, especially as the 27 September 2026 expiry for the largest EVGAT option series approaches.

Potential dilution from convertible securities exercises may affect earnings per share and shareholder ownership percentages, critical factors for investment decisions. Shareholders are advised to track forthcoming company disclosures on capital structure changes and option expiry developments.